⑴ Official in charge of disbursement of the procuring entity : Takashi Yamaguchi, Director, National Hospital Organization Mito Medical Center

⑵ Classification of the products to be procured : 4

⑶ Nature and quantity of the products to be purchased : Revlimid Capsules 5mg (5mg/PTP104) 1 case (PTP10) 410 cases, Pomalyst Capsules 4mg (4mg/PTP 7 CAP) 1 case 201 cases, ALPROLIX Intravenous 3000 (3000IU/1V) 1 case 39 cases

⑷ Delivery period : From October 1, 2021 to September 30, 2022

⑸ Delivery place : National Hospital Organization Mito Medical Center

⑹ Qualification for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :

① not come under Article 5 of the Regulation concerning Contract for National Hospital Organization (NHO). Furthermore, minors, Person under Conservatorship or Person under Assistance that obtainedthe consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause ;

② not come under Article 6 of the Regulation concerning Contract for NHO ;

③ have Grade A, B, C in "Sales of products" for participating in tenders by Ministry of Health, Labour and Welfare (Single qualification for every ministry and agency) in Kantou-Koushinetsu Region ;

④ prove to have obtained the firstclass-license for selling drugs in accordance with the Pharmaceutical Affairs Law ;

⑤ prove that they can deliver the drugs on the date and to the place specified by the Obligating Officer ;

⑥ meet the qualification requirements which the Obligating Officer may specify in accordance with Article 4 of the Regulation ;

⑺ Time-limit for tender : 12 : 00 September 21, 2021

⑻ Contact point for the notice : Susumu Watanabe, Director, Accounting Division, National Hospital Organization Mito Medical Center, 280 Sakuranosato Ibaraki-machi, Higashiibaraki-gun Ibaraki-ken 311-3193, Japan. TEL 029-240-7711 ext. 2015